D. Ashton

University of Colorado Boulder — United States

Neuroscience · Life Sciences

21h-index6.6kcitations79works9.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(17), Analytical Chemistry and Chromatography(12), Mass Spectrometry Techniques and Applications(9), Receptor Mechanisms and Signaling(9), Free Radicals and Antioxidants(6)

Publications79 total

Blood–Brain Barrier Dysfunction Predicts Microglial Activation After Traumatic Brain Injury in Juvenile Rats
Neurotrauma Reports·2024· 9 citedOpen Access
Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion
Journal of Psychopharmacology·2008· 15 cited
Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia
Physiology & Behavior·2007· 19 cited
Pharmacology of aripiprazole in rats: A comparison with the classical neuroleptic haloperidol
The International Journal of Neuropsychopharmacology·2006· 1 cited
Preclinical Assessment of the Feasibility of Applying Controlled Release Oral Drug Delivery to a Lead Series of Atypical Antipsychotics
Journal of Pharmaceutical Sciences·2006· 4 cited
P.3.d.022 What combination of pharmacological effects can explain the partial reversal of PCP-disrupted social interaction in rats by atypical antipsychotics?
European Neuropsychopharmacology·2006· 1 cited
Abstract no.: 7 
Effects of gestational day 11 exposure to methylazoxymethanol acetate on Morris water maze performance, prepulse inhibition and latent inhibition in adult male Wistar rats
Fundamental and Clinical Pharmacology·2005
Differential desensitisation characteristics of human wild-type alpha 7 nicotinic receptor and human alpha(7)/5-HT3(A) chimera receptor
Biophysical Journal·2005
Calcification and gliosis in the hippocampus of adult rats with neonatal excitotoxic injury
Schizophrenia Research·2003
RGS gene expression changes in the dopaminergic system by specific D1 and D2 agents: Clues for receptor selectivity of RGS proteins
Schizophrenia Research·2003
Ex-vivo autoradiography: A crucial tool for developing potential therapeutic agents for the treatment of schizophrenia
Schizophrenia Research·2003
Altered acoustic startle response in mice partially deficient for glycine transporter 1
Schizophrenia Research·2003
Modulation of alpha 7 nicotinic receptors as a strategy for therapy in schizophrenia
Schizophrenia Research·2003
Evaluation of neonatal lesions of the ventral hippocampus as an animal model of schizophrenia
European Neuropsychopharmacology·2002
Neonatal neuronal overexpression of glycogen synthase kinase-3β reduces brain size in transgenic mice
Neuroscience·2002· 103 cited
Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist
Journal of Pharmacology and Experimental Therapeutics·2002· 26 cited
Novel, centrally active mGlu1 antagonists: In vitro and in vivo pharmacology
Neuropharmacology·2002· 30 cited
Oxidative DNA Damage in Prostate Cancer Patients Consuming Tomato Sauce-Based Entrees as a Whole-Food Intervention
JNCI Journal of the National Cancer Institute·2001· 417 citedOpen Access
Preclinical pharmacology of R121919, a CRFI receptor antagonist
British Journal of Pharmacology·2001
Characterization of fungal spores by laser desorption/ionization time-of-flight mass spectrometry
Rapid Communications in Mass Spectrometry·2000· 115 cited
page 1 of 4Next →

Frequent Co-authors

A. Wauquier(13), C.R. Beddell(9), J. M. Tedder(9), John C. Walton(5), David Cooper(4), R.W.A. Oliver(4), Richard Palmer(3), Salvador Moncada(3), Peter Francis(3), Kevin J. Welham(3), Klára Valkó(3), Gilbert Clincke(3), Rik Willems(3), Anna Leone(2), Marek Domin(2), J.E. Leysen(2), E. De Prins(2), Sarah J. C. Craig(2), B.N. Green(2), L Chen(1)